NL-OMON37344撤回2 期
A randomized double blind placebo controlled study on the effects of fenretinide Lym-X-Sorb on insulin sensitivity in obese insulin resistant subjects - The effects of fenretinide on insulin sensitivity
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Post menopausal female
- •Age 40-65 years
- •BMI * 30 kg * m-2
- •HOMA-IR * 2.7
- •Signed informed consent
排除标准
- •T2DM treated with medication other than metformin or sulfonylurea derivates
- •Any medical condition except for glucose intolerance, T2DM, hypertension and secondary dyslipidemia
- •Prolonged PTT/aPTT or thrombocytopenia
- •Retinol levels of < 1.8 uM
研究者
相似试验
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”Atopic dermatitisEUCTR2018-004705-26-ESSanofi Aventis Groupe188
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patientsAtopic dermatitisEUCTR2018-004705-26-ITSANOFI-AVENTIS GROUPE188
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”MedDRA version: 20.0Level: PTClassification code 10012438Term: Dermatitis atopicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersAtopic dermatitisEUCTR2018-004705-26-FRSanofi Aventis Groupe268
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”Atopic dermatitisEUCTR2018-004705-26-DESanofi Aventis Groupe268
进行中（未招募）
1 期
SAR231893-LPS15497- Dupilumab effect on Sleep in AD patients”MedDRA version: 20.0Level: PTClassification code 10012438Term: Dermatitis atopicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersAtopic dermatitisEUCTR2018-004705-26-GBSanofi Aventis Groupe268